Cullen/Frost Bankers’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$1K 1084
2022
Q1
$1K Hold
2
﹤0.01% 1084
2021
Q4
$1K Buy
+2
New +$960 ﹤0.01% 1104
2021
Q3
Sell
-85
Closed -$40K 1209
2021
Q2
$40K Sell
85
-4
-4% -$1.92K ﹤0.01% 826
2021
Q1
$41K Hold
89
﹤0.01% 759
2020
Q4
$47K Hold
89
﹤0.01% 721
2020
Q3
$43K Sell
89
-90
-50% -$44.1K ﹤0.01% 700
2020
Q2
$81K Buy
+179
New +$79.9K ﹤0.01% 574
2020
Q1
Sell
-45
Closed -$20K 918
2019
Q4
$20K Hold
45
﹤0.01% 784
2019
Q3
$19K Hold
45
﹤0.01% 728
2019
Q2
$16K Sell
45
-144
-76% -$48.1K ﹤0.01% 743
2019
Q1
$60K Buy
+189
New +$58K ﹤0.01% 543

Other funds holding CHE

Cullen/Frost Bankers's CHE Position: Q2 2022 in Review

Cullen/Frost Bankers sold out of Chemed (CHE) in Q2 2022, closing a stake of 2 shares — an estimated $1K sold.

Cullen/Frost Bankers first reported a position in CHE in Q1 2019 and held it in 11 quarters. The position peaked at $81K in Q2 2020. 429 funds tracked by Wall St. Rank hold CHE as of Q2 2022.

  • Cullen/Frost Bankers reported no remaining Chemed position as of Q2 2022 after selling out during the quarter.
  • Cullen/Frost Bankers sold 2 Chemed shares in Q2 2022, an estimated $1K.
  • Cullen/Frost Bankers first reported a position in Chemed in Q1 2019 and held it in 11 quarters.
  • Cullen/Frost Bankers's Chemed position peaked at $81K in Q2 2020.
  • 429 funds tracked by Wall St. Rank held Chemed as of Q2 2022.

Based on Cullen/Frost Bankers's 13F filing for Q2 2022, filed 5 Aug 2022.